EI
EAM Investors Portfolio holdings
AUM
$660M
This Quarter Return
+29.08%
1 Year Return
+271.72%
3 Year Return
+5,059.16%
5 Year Return
+72,876.1%
10 Year Return
+9,525,948.1%
AUM
$635M
AUM Growth
+$635M
(-16%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-28.18%
Top 10 Holdings %
Top 10 Hldgs %
8.47%
Holding
431
New
122
Increased
24
Reduced
159
Closed
124
Top Buys
| 1 |
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
|
$4.62M |
| 2 |
Teladoc Health
TDOC
|
$4.58M |
| 3 |
Esperion Therapeutics
ESPR
|
$4.53M |
| 4 |
Extreme Networks
EXTR
|
$4.41M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$4.17M |
Top Sells
| 1 |
HZN
Horizon Global Corporation
HZN
|
$7.39M |
| 2 |
REN
Resolute Energy Corporaton
REN
|
$5.61M |
| 3 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$5.59M |
| 4 |
HSKA
Heska Corp
HSKA
|
$5.22M |
| 5 |
SHYF
The Shyft Group
SHYF
|
$5.1M |
Sector Composition
| 1 | Technology | 22.07% |
| 2 | Healthcare | 21.95% |
| 3 | Industrials | 15.49% |
| 4 | Financials | 10.29% |
| 5 | Consumer Discretionary | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AXT Inc
AXTI
$134M
| $3.9M | 0.61% | 672,506 +10,399 | +2% | +$60.3K |
|
|
TWNK
27
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $3.89M | 0.61% | 245,019 +9,677 | +4% | +$154K |
|
28
TG Therapeutics
TGTX
$4.65B
| $3.86M | 0.61% | +330,950 | New | +$3.86M |
|
29
Aclaris Therapeutics
ACRS
$209M
| $3.85M | 0.61% | 129,066 -9,550 | -7% | -$285K |
|
|
KATE
30
DELISTED
Kate Spade & Company
KATE
| $3.83M | 0.6% | +165,020 | New | +$3.83M |
|
|
OCLR
31
DELISTED
Oclaro Inc.
OCLR
| $3.82M | 0.6% | 388,893 -82,057 | -17% | -$806K |
|
|
IBTX
32
DELISTED
Independent Bank Group, Inc.
IBTX
| $3.81M | 0.6% | 59,186 -6,279 | -10% | -$404K |
|
|
MB
33
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $3.8M | 0.6% | 138,326 -53,822 | -28% | -$1.48M |
|
34
EchoStar
SATS
$17.8B
| $3.79M | 0.6% | 66,494 +4,595 | +7% | +$262K |
|
35
Brink's
BCO
$4.67B
| $3.74M | 0.59% | +70,023 | New | +$3.74M |
|
36
Merit Medical Systems
MMSI
$5.36B
| $3.74M | 0.59% | +129,529 | New | +$3.74M |
|
|
JBTM
37
JBT Marel Corporation
JBTM
$7.45B
| $3.74M | 0.59% | 42,539 +1,463 | +4% | +$129K |
|
38
Glaukos
GKOS
$5.5B
| $3.71M | 0.58% | 72,298 -5,644 | -7% | -$290K |
|
39
Visteon
VC
$3.38B
| $3.71M | 0.58% | 37,850 +2,308 | +6% | +$226K |
|
|
CLVS
40
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.69M | 0.58% | +57,882 | New | +$3.69M |
|
41
Preferred Bank
PFBC
$1.17B
| $3.67M | 0.58% | 68,351 -18,976 | -22% | -$1.02M |
|
42
Exact Sciences
EXAS
$8.98B
| $3.66M | 0.58% | +154,911 | New | +$3.66M |
|
|
FLXN
43
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.57M | 0.56% | 132,595 +95,713 | +260% | +$2.58M |
|
|
GBT
44
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.55M | 0.56% | +96,225 | New | +$3.55M |
|
|
AVTA
45
DELISTED
Avantax, Inc. Common Stock
AVTA
| $3.54M | 0.56% | +204,812 | New | +$3.54M |
|
|
TSRO
46
DELISTED
TESARO, Inc.
TSRO
| $3.52M | 0.55% | 22,871 +1,142 | +5% | +$176K |
|
47
Karyopharm Therapeutics
KPTI
$61.7M
| $3.46M | 0.55% | +269,611 | New | +$3.46M |
|
|
CSII
48
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.45M | 0.54% | 121,923 -8,040 | -6% | -$227K |
|
|
AVXS
49
DELISTED
AveXis, Inc. Common Stock
AVXS
| $3.44M | 0.54% | 45,215 -2,980 | -6% | -$227K |
|
|
RP
50
DELISTED
RealPage, Inc.
RP
| $3.37M | 0.53% | 96,477 -6,360 | -6% | -$222K |
|